Seth Alpna
- SEC CIK
- 0001721020
In the past year, 1 open-market sale filing worth $28.1K and no purchases.
Current role at each company
- KROS Keros Therapeutics, Inc.Directoras of Jun 5, 2026
- TECH BIO-TECHNE CorpDirectoras of Nov 3, 2025
- SGEN Seagen Inc.Directoras of Dec 15, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $28.1K
- 1 filing
- Net
- −$28.1K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Seth Alpna as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
KROS Keros Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 5, 2026 (view filing) | Jun 4 | 1 day | Seth AlpnaDirector | SSale | −2.63K | $10.72 | −$28.1K | −21.2%9.77K after | 10b5-1 |